MentionFox
Home › funding signals › PANGIA BIOTECH, INC.
Form D · on the record

PANGIA BIOTECH — $1.58M Form D filing, May 2026

PANGIA BIOTECH, INC. filed a Form D with the Securities and Exchange Commission on 2026-05-11.

PANGIA BIOTECH, INC. filed a Form D notice of an exempt securities offering with the SEC on May 11, 2026. The filing reports $1.58M sold. Its industry group is Biotechnology. It names Holly Magliochetti (Executive Officer, Director), Joseph Frattaroli (Executive Officer), Obdulio Piloto (Executive Officer) (SEC Form D, May 11, 2026).

125 companies raised this week.

Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.

Andersen Aggregator LLC$1.9BBusiness services
AT Umbrella LLC$1.9BBusiness services
Legora, Inc.$221MAI and software
MD INVESTMENT LLC$169MBusiness services
Serval Inc.$149MAI and software
Check one company free

3 more Biotechnology raises in Florida, May 2026 ↓

Is this your company?

Key facts

Run the free check on PANGIA BIOTECH, INC. →

Sell to companies like PANGIA BIOTECH, INC? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

PANGIA BIOTECH, INC.

New Form D on file · 2026-05-11 · the record

$1.58M
raise on the record
D
filing
18
investors in
FLORIDA
based
Open the record →

What the record says

FilingForm D
Filed2026-05-11
Industry groupBiotechnology
Entity typeCorporation
Incorporated inFLORIDA
Year formed2023
BasedDELRAY BEACH, FLORIDA
CIK2125789
Accession0001213900-26-054301

Pitching, partnering or investing alongside them? See who really runs and owns PANGIA BIOTECH, INC.

Free to see. No signup.

Keep reading

More on the people and the money behind PANGIA BIOTECH, INC., from the filings we hold.

More raises like this

Biotechnology raises by companies based in Florida, filed in May 2026, largest first.

What do you want to do with PANGIA BIOTECH, INC.?

Get the full cited report on PANGIA BIOTECH, INC.

What the filing shows about PANGIA BIOTECH, INC.

  • 18 investors had already put money in when it filed.
  • The filing names 5 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on PANGIA BIOTECH, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Who the filing names, and in what role

The filing gives PANGIA BIOTECH, INC.'s address as 4733 West Atlantic Avenue, Suite C-14, Delray Beach, FL 33445.

What the filing says

  • Offered: $1,580,000. Sold: $1,580,000. Left to sell: nothing, all of it is sold. (filing)
  • Investors: 18 had already invested. (filing)
  • Date of first sale: April 8, 2026. (filing)
  • Types of securities: Debt; Options, warrants or other rights to acquire another security. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)
  • On the amounts offered and sold: the filing adds “There were two closings. The first closing total amount sold was $1,030,000 including 10 investors. The second closing total amount sold was $550,000 including 8 investors. Total amount sold was $1,580,000.” (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on PANGIA BIOTECH, INC. See pricing

Is PANGIA BIOTECH, INC. a real, registered company?

PANGIA BIOTECH, INC. is a registered filer with the SEC (CIK 2125789) and has filed since 2026-05-11. 1 filing is on record, the latest on 2026-05-11.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs PANGIA BIOTECH, INC.?

PANGIA BIOTECH, INC.'s Form D of 2026-05-11 names Holly Magliochetti, Joseph Frattaroli, Obdulio Piloto and 2 more as its officers, directors or promoters.

How much has PANGIA BIOTECH, INC. raised?

Its new offerings report $1.58M sold across 1 offering, as its own filings state.

Biotechnology · by week
This raise, $1.58M, filed week of May 11

Trailing twelve months. 766 filings in Biotechnology, totalled by week. The dot is this raise, $1.58M, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on PANGIA BIOTECH, INC.?

What the filing shows about PANGIA BIOTECH, INC.

  • 18 investors had already put money in when it filed.
  • The filing names 5 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on PANGIA BIOTECH, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on PANGIA BIOTECH, INC. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind PANGIA BIOTECH, INC.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov.

RSS

Tools for this story

Each opens in a new tab, filled in for PANGIA BIOTECH, INC.. With no account yet, you sign up free and land on the result.

On these startup lists

Biotech startups

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

PANGIA BIOTECH, INC.: Raised $1.58M, Form D filed 2026-05-11
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/pangia-biotech-inc-form-d-26054301
Last updated 2026-10-26
Primary record: SEC filing 1 · SEC filing 2
PANGIA BIOTECH raised $1.58M — SEC Form D filing, May 2026. MentionFox, 2026-10-26. https://mentionfox.com/funding/pangia-biotech-inc-form-d-26054301